Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 2,300 shares, a decline of 94.1% from the April 30th total of 39,000 shares. Approximately 0.0% of the shares of the company are short sold. […]
Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the target of a large decrease in short interest in the month of April. As of April 30th, there was short interest totalling 39,000 shares, a decrease of 87.6% from the April 15th total of 313,600 shares. Approximately 0.6% of the shares of the stock are short sold. […]
Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating)’s stock price traded down 1.3% on Tuesday . The stock traded as low as $0.75 and last traded at $0.79. 17,025 shares were traded during mid-day trading, a decline of 79% from the average session volume of 81,457 shares. The stock had previously closed at $0.80. Analyst Ratings Changes […]
Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 221,100 shares, a decline of 31.3% from the April 30th total of 321,800 shares. Approximately 4.8% of the shares of the company are short sold. […]